Skip to content

News releases

The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.

Newfoundland and Labrador Announces Transition to Cost-Saving Biosimilar Medicines

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, welcomes the announcement by the Government of Newfoundland and Labrador that it is implementing a “switching” or transitioning policy to expand the use of biosimilar biologic medicines for its public drug program.
Read more

Biosimilars Canada Announces Board Chair and Vice-Chair

Biosimilars Canada is pleased to announce the unanimous election of Mr. Mike Woolcock, Senior Vice President of the Apobiologix division of Apotex, as Chair of the Biosimilars Canada Board. Mr. Mike Casia, President and Managing Director of Organon Canada, has been unanimously elected as Vice-Chair of the Biosimilars Canada Board.
Read more

Canada’s Largest Public Drug Plan Announces Transition to Cost-Saving Biosimilar Medicines

Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today welcomed the announcement by Ontario Health Minister Sylvia Jones that the province will implement a “switching” or transitioning policy to expand the use of biosimilar biologic medicines for the Ontario Drug Benefit (ODB) program in 2023.
Read more

The Value of Biosimilars for Public Drug Plans

There are few solutions to such healthcare challenges that allow governments to provide more value to taxpayers for the same dollars. But that is precisely the value proposition provided through the expanded use of biosimilar medicines.
Read more

Saskatchewan Becomes Sixth Province to Implement Biosimilar Switching Initiative

Toronto – October 20, 2022 – Biosimilars Canada, a national association representing Canada’s biosimilar medicines industry, today welcomed the announcement by the Government of Saskatchewan that it will implement a “switching” or transitioning policy to expand the use of biosimilar...
Read more

“Make the switch”: Biosimilars Canada pitches Ontario on savings, benefits of switching to biosimilars

Biosimilars Canada hosted a press conference at Queen’s Park, calling on the government of Premier Doug Ford to implement a biosimilars switching policy.
Read more